
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquapl... Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0788 | 12.2894572676 | 0.6412 | 0.726 | 0.616 | 41162 | 0.67800491 | CS |
4 | -0.09 | -11.1111111111 | 0.81 | 0.822 | 0.616 | 57971 | 0.72460175 | CS |
12 | 0.12 | 20 | 0.6 | 1.45 | 0.55 | 1663604 | 1.16506848 | CS |
26 | 0.0598 | 9.05786125417 | 0.6602 | 1.45 | 0.55 | 762426 | 1.15333734 | CS |
52 | -0.74 | -50.6849315068 | 1.46 | 1.79 | 0.55 | 409159 | 1.15425931 | CS |
156 | -2.12 | -74.6478873239 | 2.84 | 3.35 | 0.55 | 186842 | 1.26522724 | CS |
260 | -3.63 | -83.4482758621 | 4.35 | 17.75 | 0.55 | 272780 | 4.60744508 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales